Stanford University
257 Campus Drive
Hagey Laboratory GK200
Stanford
California
94305-5826
United States
21 articles with Stanford University
-
Scientists from Stanford University investigated the effectiveness of an oral tablet flu vaccine called VXA-A1.1 by Vaxart, which uses cellular correlates of protection.
-
Research on the ever-evolving SARS-CoV-2 virus continues as scientists scramble to make sense of it and find cures. Here's a look.
-
Students, Venture Capitalists Launch Equity-Free Program To Support Future Biotech Leaders
9/28/2021
Nucleate, the non-profit organization seeking to support future leaders in the life sciences industry, announced its official launch and immediately opened applications to its Activator program. -
Pixium Vision expands collaboration with Stanford University on next generation Prima System implants
9/8/2021
Pixium Vision SA announces expansion of collaboration with the academic partner Stanford University to develop the second generation of implants for its bionic vision Prima System for dry age-related macular degeneration.
-
BridgeBio Pharma Announces Collaborations with Three Academic Research Institutions
7/8/2021
BridgeBio Pharma, Inc. today announced three new academic collaborations with MUSC Foundation for Research Development, Stanford University and the University of Pittsburgh (Pitt) to translate cutting-edge discoveries into potential therapies for patients with genetic diseases and genetically driven cancers.
-
New Life-Changing Test for Patients Diagnosed With Peanut Allergy
6/15/2021
AllerGenis announced the publication of a peer-reviewed study entitled, "Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping." Conducted by leading global experts in pediatric allergy and immunology from the Icahn School of Medicine at Mount Sinai, Stanford University and Kings College, the study found the AllerGenis peanut diagnostic blood test demonstrates accuracy significantly and statistically superior to all other established diagnostic tests.
-
Forbes highlights its "30 Under 30" list who are beginning to make their mark in the biopharma and healthcare industries.
-
Global WiDS Announces the WiDS High School Outreach Program
3/2/2020
At the Stanford Women in Data Science Conference, a new WiDS High School outreach program was announced to inspire high school students to consider careers involving data science, artificial intelligence and other related areas at their annual WiDS Conference.
-
Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
1/13/2020
Abeona Therapeutics Inc., a fully-integrated leader in gene and cell therapy, announced that it has received Institutional Review Board approval from Stanford University to commence the VIITAL™ study, the Company’s pivotal Phase 3 clinical trial evaluating EB-101 for the treatment of recessive dystrophic epidermolysis bullosa.
-
AI System Accurately Detects Key Findings in Chest X-Rays of Pneumonia Patients Within 10 Seconds; Study Finds Promise of Faster Treatment
10/1/2019
Researchers from Intermountain Healthcare and Stanford University say 10 seconds is about how quickly a new system they studied that utilizes artificial intelligence took to accurately identify key findings in chest X-rays of patients in the emergency department suspected of having pneumonia.
-
JF Healthcare's AI Technology Is First to Beat Radiologists in Stanford Chest X-ray Diagnostic Competition
8/21/2019
JF Healthcare, a medical diagnostic start-up based in Nanchang, China, is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence to human experts in interpreting chest x-rays.
-
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
-
Both the Chinese and American researchers involved in using CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples in China are under investigation. The work has also received near-universal condemnation worldwide.
-
Every year, Forbes creates a list of 30 Under 30, people under the age of 30 who have made a mark and show promise in various areas. They just came out with the 2019 30 Under 30: Healthcare. Here we highlight a dozen of the winners for their roles in biopharma-related endeavors.
-
The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.
-
A New Laser Architecture Taps Coherent Light to Create Complex, Sophisticated Structures to Probe and Control Matter
11/5/2018
Universal light modulator may soon be a game-changer for photonics applications that require high power
-
Researchers with Stanford University Jonathan Rothbard and Lawrence Steinman, formed Katexco Pharmaceuticals. Katexco will focus on developing oral therapies for inflammatory diseases based on cannabis and nicotine receptors.
-
SunTech Drive Announces Collaboration with Stanford University and Google for Energy Internet of Things ARPA-E Project
10/23/2018
SunTech Drive is pleased to announce a new collaboration with both Stanford University and Google. The project is tied to the Department of Energy’s NODES (Networks of Distributed Energy Systems) initiative.
-
Researchers Move Closer to Completely Optical Artificial Neural Network
7/19/2018
Optical training of neural networks could lead to more efficient artificial intelligence
-
Andrew Huberman, researcher in the Stanford University Department of Neurobiology, is taking an unusual approach to investigating possible treatments for glaucoma and anxiety disorders—virtual reality.